Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In
  • Become a Member
  • MB Vision
  • Members
    • Become a Member
      • Types & Rates
    • Benefits
      • Savings and Rewards
    • Member News
    • Member Events
    • Career Center
    • Directory
    • Pay Company Dues
    • FAQs
  • Events
    • Upcoming
    • Types of Events
    • Sponsorship Opportunities
    • Massachusetts: The State of Possible
    • Align Summit
    • Member Events
  • Innovation
    • About
    • Drive
      • Application
      • Alumni
      • Partners – MassBio
      • Partners โ€“ SCbio
      • Get Involved
      • FAQs
    • CEO & Founder Link
    • Align Summit
    • Partnering
    • Termeer Ascend
    • Sponsorship Opportunities
  • Savings
    • MassBioEdge
    • Summer Savings Week
  • Conference Center
    • About MassBioHub
    • Packages & Special Offers
    • Venue Specifications
    • Reserve Today
  • Policy & Advocacy
    • Policy & Advocacy Efforts
    • Diversity, Equity, and Inclusion
      • DEI Report
      • Resource Center
      • Open Letter 2.0
      • Bioversity
    • Economic Development
      • BioReadyยฎ Communities
    • Workforce Development
      • Bioversity
      • Termeer Ascend
    • Vision 2030
    • This is the place.
    • Industry Reports
      • Federal Actions Impact Report
      • Industry Snapshot
      • Biopharma Funding Report
      • DEI Report
      • MAย Life Sciences Workforce
  • About
    • About MassBio
    • News & Thought Leadership
    • MB Vision
    • The Studio at Kendall Square
    • Sponsorship Opportunities
    • Staff
    • Board
    • Contact Us
  • Sign In
  • Become a Member
  • MB Vision
Open search form

Member News

Click to Open Main Menu
Whitepapers

Top Commercial Considerations for Leaders Securing Early-Stage Investment in 2026

Mar 25, 2026

Posted by GreyRigge

News

Castor adds nearly 10 commercial Phase II/III eCOA studies in H2 2025

Mar 24, 2026

Posted by Castor

News

RxCelerate launches RxPlorerโ„ข: A new protein metastate discovery platform, unlocking new possibilities for screening against undruggable targets

Mar 24, 2026

Posted by RxCelerate Inc.

News

Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology

Mar 20, 2026

Posted by Pharvaris, Inc.

Training

Master of Science in Bioethics: Virtual Format for Working Professionals

Mar 18, 2026

Posted by Harvard Medical School

News

New Podcast Episode

Mar 18, 2026

Posted by tranScrip

News

๐Ÿงฌ ๐€๐€๐• ๐ ๐ž๐ง๐ž ๐ญ๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐ฆ๐ข๐ฅ๐ž๐ฌ๐ญ๐จ๐ง๐ž ๐ข๐ง ๐„๐ฎ๐ซ๐จ๐ฉ๐ž

Mar 17, 2026

News

AeroSafe Global Joins MassBio to Advance Pharmaceutical Distribution

Mar 16, 2026

Posted by AeroSafe Global

News

Validation of Patient-Reported Outcomes in the On-Demand Treatment of Hereditary Angioedema Attacks Published in Clinical Reviews in Allergy & Immunology

Mar 13, 2026

Posted by Pharvaris, Inc.

News

Our version of March Madness

Mar 12, 2026

Posted by labmovers

News

Empowering Success in Small Pharma/ Biotech: Leveraging People and Process for Optimal Results

Mar 09, 2026

Posted by Halloran Consulting Group, A PLG Company

News

Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment

Mar 06, 2026

Posted by Quotient Sciences

Page 5 of 203FIRSTPrev...34567...102030...NextLAST

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • News & Thought Leadership
  • Join Email List
  • Pay Company Dues
  • Join Today
  • Contact
  • Privacy Policy
  • © 2026 All Rights Reserved